NCT00683410已完成不适用
A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Pneumococcal Conjugate Vaccine, 7-valent (Prevenar) 0.5 mL by Intramuscular Injection
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 3,366 人开始时间: 2007年4月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 3,366
- 主要终点
- Number of Participants With Spontaneous Adverse Events
研究概览
简要总结
To collect post-marketing information on the safety of Prevenar in Filipino patients
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •All patients from the study center who received or will receive at least one dose of Prevenar according to the approved product indication.
排除标准
- •Previously discontinued Prevenar therapy due to safety concerns.
结局指标
主要结局
Number of Participants With Spontaneous Adverse Events
时间窗: 30 days post injection up to 3 years
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active BladderOver Active BladderNCT01260311Pfizer508
已完成
不适用
Prevenar13 Post Market SurveillanceHealthyNCT01509105Pfizer649
已完成
不适用
Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino PatientsPainNCT02215798Boehringer Ingelheim269
Unknown
不适用
Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word（STONE）Wet Age-related Macular Degeneration (wAMD)NCT03054818Chengdu Kanghong Biotech Co., Ltd.4,000
已完成
不适用
Post Market Surveillance to Observe Safety of Prevenar13™ in AdultsPneumococcal DiseaseNCT01834222Pfizer659